1-anilino-8-naphthalenesulfonate has been researched along with Pancreatic Insufficiency in 186 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifteen patients with cystic fibrosis and pancreatic insufficiency were studied during four randomised seven day treatment periods in which they received only pancreatic supplement (Pancrelipase, 27 capsules per day) or supplement plus cimetidine (20 mg/kg body weight/24 h) or sodium bicarbonate (15 g/m2/24 h) alone or in combination." | 9.05 | Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. ( Bell, L; Corey, ML; Durie, PR; Forstner, GG; Linton, W, 1980) |
| "Forty-six subjects (20 chronic pancreatitis, 7 chronic liver disease, 7 recovered from acute pancreatitis, 2 Crohn's disease, and 10 healthy controls) classified by S-C test as having normal pancreatic function (26 subjects), or moderate (10 subjects) and severe (10 cases) pancreatic insufficiency, were given, on different days, 1 g of oral PABA or 348 mg of oral fluorescein dilaurate." | 7.67 | Serum PABA and fluorescein in the course of Bz-Ty-PABA and pancreolauryl test as an index of exocrine pancreatic insufficiency. ( Angelini, G; Benini, L; Brocco, G; Cavallini, G; Chech, G; Dalle Molle, L; Micciolo, R; Piubello, W; Riela, A; Vantini, I, 1985) |
| " In this controlled randomized study, 8 hospitalized patients with severe exocrine pancreatic insufficiency and considerable steatorrhoea (greater than 15 g faecal fat/day) were treated with a conventional pancreatic enzyme preparation (Pankreon 700; 3 X 3 dragees daily), with (300 mg) and without cimetidine before meals, and with a new pH-sensitive enzyme preparation (Kreon; 3 X 6 capsules daily) comprising acid-protected granules." | 5.06 | Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? ( Creutzfeldt, W; Göke, B; Lankisch, PG; Lembcke, B, 1986) |
| "Fifteen patients with cystic fibrosis and pancreatic insufficiency were studied during four randomised seven day treatment periods in which they received only pancreatic supplement (Pancrelipase, 27 capsules per day) or supplement plus cimetidine (20 mg/kg body weight/24 h) or sodium bicarbonate (15 g/m2/24 h) alone or in combination." | 5.05 | Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. ( Bell, L; Corey, ML; Durie, PR; Forstner, GG; Linton, W, 1980) |
| "Forty-six subjects (20 chronic pancreatitis, 7 chronic liver disease, 7 recovered from acute pancreatitis, 2 Crohn's disease, and 10 healthy controls) classified by S-C test as having normal pancreatic function (26 subjects), or moderate (10 subjects) and severe (10 cases) pancreatic insufficiency, were given, on different days, 1 g of oral PABA or 348 mg of oral fluorescein dilaurate." | 3.67 | Serum PABA and fluorescein in the course of Bz-Ty-PABA and pancreolauryl test as an index of exocrine pancreatic insufficiency. ( Angelini, G; Benini, L; Brocco, G; Cavallini, G; Chech, G; Dalle Molle, L; Micciolo, R; Piubello, W; Riela, A; Vantini, I, 1985) |
| "The effect of the addition of sodium bicarbonate, aluminum hydroxide, magnesium hydroxide, calcium carbonate, or cimetidine to supplemental pancreatic enzyme therapy was investigated in patients with severe exocrine pancreatic insufficiency." | 3.66 | Pancreatic enzyme replacement: the effect of antacids or cimetidine. ( Graham, DY, 1982) |
| "The Food and Drug Administration in 2006 required that all pancreatic enzyme products demonstrate bioavailability of lipase, amylase, and protease in the proximal small intestine." | 2.94 | Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency. ( Karnik, N; Lieb, JG; Patel, D; Toskes, PP, 2020) |
| " Adverse events were mostly gastrointestinal in nature and were more common in the group receiving NM-BL." | 2.82 | Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial. ( Ahrens, RC; Forssmann, K; Graff, G; Heubi, JE; Jain, R; Schaeffer, D; Sollo, N; Strausbaugh, S; Witte, S, 2016) |
| " PA bioavailability estimates for CF subjects without pancreatic enzyme administration (1." | 2.80 | Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency. ( Barrett, JS; Mascarenhas, MR; Mondick, J; Schall, JI; Stallings, VA; Wilson, M, 2015) |
| " All of the patients were required to discontinue their long-term use of porcine PERTs at the time of enrollment." | 2.77 | Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis. ( Borowitz, D; Brettman, LR; Campion, M; Stevens, C; Thompson, H; Wilschanski, M, 2012) |
| " At the other dosing levels, the mean coefficient of fat and nitrogen absorption increases were 19." | 2.72 | Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients. ( Ahrens, R; Aitken, ML; Borowitz, D; Dunitz, J; Goss, CH; Hayes, D; Hendeles, L; Konstan, MW; Mahl, TC; Moss, R; Murray, FT; Newman, L; O'Rourke, A; Oermann, CM; Orenstein, D; Stevens, C; Wagener, J; Young, KR, 2006) |
| " Excellent fat and protein absorption was achieved with minimal adverse events and safe doses." | 2.71 | Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy. ( Colin, P; Duggan, C; Eigen, H; Konstan, MW; Sherman, JM; Stern, RC; Trout, JR; Wagener, JS; Wohl, ME, 2004) |
| "A dose-response relationship between the amount of lipase administered with each meal and a reduction in faecal fat was not evident." | 2.68 | Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults. ( Graham, DY; Opekun, AR; Sutton, FM, 1997) |
| "Chronic pancreatitis was alcohol-related in 23 patients, previous surgery was performed in 9, 16 had diabetes and all had steatorrhoea (fat balance > 10g/24h)." | 2.68 | Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis. ( Buedts, K; Cremer, M; Delhaye, M; Gohimont, AC; Meuris, S, 1996) |
| " A high-strength preparation is thought to release relatively less enzyme activity in the small intestine, forcing patients to increase their dosage and possibly creating a dangerous enzyme hyperconcentration in the large intestine." | 2.68 | High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial. ( Cabrini, G; Lancellotti, L; Mastella, G; Zanolla, L, 1996) |
| " Capsule dosage was adjusted to a ratio of approximately 3:1." | 2.67 | Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. ( Bowden, MW; Byers, CA; Dodge, JA; Guilford, SA; McCracken, KJ; Morrison, G; Morrison, JM; Redmond, AO, 1992) |
| " Finally, the higher potency preparations were more effective per capsule and reduced capsule dosage is therefore attainable." | 2.67 | Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency. ( Clague, A; Cleghorn, GJ; Shepherd, RW; Thomson, M, 1993) |
| "In the past 10 years, treatment of acute pancreatitis has moved towards a multidisciplinary, tailored, and minimally invasive approach." | 2.66 | Acute pancreatitis. ( Besselink, MG; Boermeester, MA; Bouwense, SA; Boxhoorn, L; Bruno, MJ; van Santvoort, HC; Verdonk, RC; Voermans, RP, 2020) |
| "In an attempt to critically examine the therapeutic efficacy of pH-sensitive enteric-coated pancreatic enzyme preparations in patients with pancreatic insufficiency due to cystic fibrosis, postprandial duodenal concentration and recovery of orally administered pancreatic enzymes, duodenal pH, and coefficient of fat absorption were determined in eight cases after ingestion of equivalent dosage of enteric-coated as well as conventional enzyme preparations." | 2.66 | Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. ( Appler, M; Dutta, SK; Hubbard, VS, 1988) |
| " Bioavailability was measured by using a double intubation method in 13 patients with severe pancreatic insufficiency." | 2.66 | [Comparison of fungal lipase and pancreatic lipase in exocrine pancreatic insufficiency in man. Study of their in vitro properties and intraduodenal bioavailability]. ( Bommelaer, G; Bouisson, M; Moreau, J; Pignal, F; Ribet, A; Saint-Marc-Girardin, MF, 1988) |
| "Pancreatic insufficiency is a major consequence of pancreatic diseases leading to a loss of pancreatic parenchyma, obstruction of the main pancreatic duct, decreased pancreatic stimulation, or acid-mediated inactivation of pancreatic enzymes." | 2.47 | Pancreatic exocrine insufficiency: diagnosis and treatment. ( Domínguez-Muñoz, JE, 2011) |
| " While dosage requirements vary widely and therefore have to be tried out individually, the choice of the adequate preparation should be influenced by the realization of the physiological and pathophysiological characteristics of the individual patient and the pharmaceutical characteristics of the different supplements." | 2.38 | [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy]. ( Fölsch, UR; Löser, C, 1991) |
| "To establish the diagnosis of acute pancreatitis the estimation of amylase in serum and urine, lipase and radio-immunoreactive trypsin in the serum are useful." | 2.36 | [Examination of pancreatic function in children with special reference to the PABA-test (author's transl)]. ( Dockter, G; Sitzmann, FC, 1980) |
| "CFA has been used to assess treatment of pancreatic insufficiency but does not correlate with pancreatic enzyme replacement therapy dose." | 1.91 | Validation of an omega-3 substrate challenge absorption test as an indicator of global fat lipolysis. ( Borowitz, DS; Freedman, SD; Gallotto, R; Pierzynowska, K; Pierzynowski, S; Sathe, M; Zaworski, K, 2023) |
| "Exocrine pancreatic insufficiency was proposed as the underlying cause." | 1.43 | Exocrine pancreatic function in children with Alagille syndrome. ( Gliwicz, D; Jankowska, I; Lisowska, A; Miśkiewicz-Chotnicka, A; Walkowiak, J; Wierzbicka, A, 2016) |
| " An individualized therapy is required that includes high dosage of enzymatic units, usage of enteric coating, and addition of gastric proton pump inhibitors." | 1.43 | Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency. ( Aldag, I; Brock, A; Edskes, S; Hartmann, M; Herzog, T; Schnekenburger, J; Uhl, W, 2016) |
| "In this study population, no correlation between an enzyme dosage and the degree of fat malabsorption was found; however, a CFA below 85% was found in 24% of the measurements." | 1.42 | Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis. ( Houwen, RH; van der Ent, CK; Woestenenk, JW, 2015) |
| " Tests make it possible to choose the initial pancreatic enzyme dosage and are beneficial during the treatment for pancreatic enzyme dose correction." | 1.40 | [The clinical application of 13C-breath tests in pancreatic diseases]. ( Cherniavskiĭ, VV, 2014) |
| "Patients attending US cystic fibrosis programs achieving highest nutritional outcomes, measured by mean BMI percentile, have higher enzyme dosing than those attending programs at lower performance levels." | 1.40 | Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis. ( Haupt, ME; Kwasny, MJ; McColley, SA; Schechter, MS, 2014) |
| "Exocrine pancreatic insufficiency was irreversible in alcoholic rats without CP after alcohol withdrawal." | 1.36 | Irreversible exocrine pancreatic insufficiency in alcoholic rats without chronic pancreatitis after alcohol withdrawal. ( Huang, Z; Li, J; Liu, R; Tang, C; Wang, R; Zhou, C, 2010) |
| "Pancreatitis is a rare complication among patients with CF." | 1.33 | Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. ( De Boeck, K; Kerem, E; Proesmans, M; Weren, M, 2005) |
| "Among the 36 patients with alcoholic pancreatitis, most had impaired pancreatic function at both duodenal intubation (8/8, 100%) and at AACT (22/28, 78." | 1.32 | Exocrine pancreatic function after alcoholic or biliary acute pancreatitis. ( Gullo, L; Migliori, M; Pezzilli, R; Tomassetti, P, 2004) |
| "Chronic pancreatitis is a common cause of exocrine pancreatic insufficiency (EPI) in humans and cats but is rarely recognised in dogs in which pancreatic acinar atrophy (PAA) is reportedly more common." | 1.32 | Exocrine pancreatic insufficiency as an end stage of pancreatitis in four dogs. ( Watson, PJ, 2003) |
| " To evaluate the relationship between fibrosing colonopathy and supplemental pancreatic enzymes we reviewed our dosing of enzymes prior to fibrosing colonopathy development and then evaluated the subsequent effect of drastically reducing pancreatic enzyme dose." | 1.30 | Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. ( Chong, SK; Heilman, DK; Hollingsworth, J; Maguiness, KM; Stevens, JC, 1998) |
| "Treatment of human exocrine pancreatic insufficiency is suboptimal." | 1.30 | Effect of bacterial or porcine lipase with low- or high-fat diets on nutrient absorption in pancreatic-insufficient dogs. ( DiMango, EP; Mizumoto, A; Rerknimitr, R; Sarr, MG; Suzuki, A, 1999) |
| " Therefore, we examined the dose-response of endogenous lipase on fat absorption." | 1.29 | Effect of replenished lipase on postcibal absorption of fat in a canine model of pancreatic insufficiency. ( Doty, JE; Gu, YG; Meyer, JH, 1994) |
| "Pancreatic insufficiency was created by pancreatic duct ligation, and the duodenal, jejunal and ileal contents were sampled through cannulas before a normal meal and 0." | 1.28 | Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation. ( Abello, J; Cuber, JC; Junien, JL; Pascaud, X; Rozé, C; Simoes-Nunes, C, 1989) |
| "Pancreatic insufficiency was associated with significantly (p less than 0." | 1.27 | Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency. ( Abrams, CK; Dutta, SK; Hamosh, M; Hamosh, P; Hubbard, VS, 1987) |
| "Patients with pancreatic insufficiency have a ravenous appetite but fail to thrive from malnutrition." | 1.26 | [Exocrine pancreatic insufficiency (author's transl)]. ( Götze, H, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (25.81) | 18.7374 |
| 1990's | 55 (29.57) | 18.2507 |
| 2000's | 30 (16.13) | 29.6817 |
| 2010's | 40 (21.51) | 24.3611 |
| 2020's | 13 (6.99) | 2.80 |
| Authors | Studies |
|---|---|
| Olsen, MF | 1 |
| Kjøller-Svarre, MS | 1 |
| Møller, G | 1 |
| Katzenstein, TL | 1 |
| Nielsen, BU | 1 |
| Pressler, T | 1 |
| Lewis, JI | 1 |
| Mathiesen, IH | 1 |
| Mølgaard, C | 1 |
| Faurholt-Jepsen, D | 1 |
| Erchinger, F | 1 |
| Tjora, E | 1 |
| Nordaas, IK | 1 |
| Dimcevski, G | 1 |
| Olesen, SS | 1 |
| Jensen, N | 1 |
| Dahl, EE | 1 |
| Borch, A | 1 |
| Nøjgaard, C | 1 |
| Novovic, S | 1 |
| Barauskas, G | 1 |
| Ignatavicius, P | 1 |
| Vujasinovic, M | 1 |
| Lőhr, M | 1 |
| Laukkarinen, J | 1 |
| Parhiala, M | 1 |
| Drewes, AM | 1 |
| Engjom, T | 1 |
| Bejjani, J | 1 |
| Allain, DC | 1 |
| Hart, PA | 2 |
| Freedman, SD | 2 |
| Zaworski, K | 1 |
| Pierzynowska, K | 2 |
| Pierzynowski, S | 4 |
| Gallotto, R | 1 |
| Sathe, M | 1 |
| Borowitz, DS | 1 |
| Wang, F | 1 |
| Wang, H | 3 |
| Fan, J | 1 |
| Zhang, Y | 1 |
| Zhao, Q | 1 |
| Lieb, JG | 1 |
| Patel, D | 1 |
| Karnik, N | 1 |
| Toskes, PP | 1 |
| Boxhoorn, L | 1 |
| Voermans, RP | 1 |
| Bouwense, SA | 1 |
| Bruno, MJ | 2 |
| Verdonk, RC | 1 |
| Boermeester, MA | 1 |
| van Santvoort, HC | 1 |
| Besselink, MG | 1 |
| Maev, IV | 2 |
| Kucheryavyy, YA | 2 |
| Gubergrits, NB | 2 |
| Bonnacker, I | 1 |
| Shelest, EA | 1 |
| Janssen-van Solingen, GP | 1 |
| Domínguez-Muñoz, JE | 3 |
| Petersen, KU | 1 |
| Malfertheiner, P | 2 |
| Mössner, J | 2 |
| Güven, B | 1 |
| Turan, NB | 1 |
| Öner, AF | 1 |
| Karaman, K | 1 |
| Çetin, M | 1 |
| Grimmelmann, I | 1 |
| Momma, M | 1 |
| Zimmer, L | 1 |
| Hassel, JC | 1 |
| Heinzerling, L | 1 |
| Pföhler, C | 1 |
| Loquai, C | 1 |
| Ruini, C | 1 |
| Utikal, J | 1 |
| Thoms, KM | 1 |
| Kähler, KC | 1 |
| Eigentler, T | 1 |
| Herbst, RA | 1 |
| Meier, F | 1 |
| Debus, D | 1 |
| Berking, C | 1 |
| Kochanek, C | 1 |
| Ugurel, S | 1 |
| Gutzmer, R | 1 |
| Pierzynowski, SG | 3 |
| Socha-Banasiak, A | 1 |
| Sobol, M | 1 |
| Skiba, G | 1 |
| Raj, S | 1 |
| Dovban, O | 1 |
| Ushakova, G | 4 |
| Woliński, J | 1 |
| Mosiichuk, N | 1 |
| Szczurek-Janicka, P | 1 |
| Pieszka, M | 1 |
| Kamyczek, M | 1 |
| Święch, E | 1 |
| Shmigel, H | 2 |
| Sonta, M | 1 |
| Czkwianianc, E | 1 |
| Alkaade, S | 1 |
| Vareedayah, AA | 1 |
| Venuti, E | 1 |
| Shishmarev, D | 1 |
| Kuchel, PW | 1 |
| Dutt, S | 1 |
| Blumenthal, CS | 1 |
| Gaskin, KJ | 3 |
| Yilmaz, A | 1 |
| Hagberg, L | 1 |
| Dehghani, L | 1 |
| Mikail, N | 1 |
| Kramkimel, N | 1 |
| Soyer, P | 1 |
| Lebtahi, R | 1 |
| Mallone, R | 1 |
| Larger, E | 1 |
| Khatkov, IE | 1 |
| Abdulkhakov, SR | 1 |
| Alekseenko, SA | 1 |
| Alikhanov, RB | 1 |
| Bakulin, IG | 1 |
| Bakulina, NV | 1 |
| Baranovskiy, AY | 1 |
| Beloborodova, EV | 1 |
| Belousova, EA | 1 |
| Voskanyan, SE | 1 |
| Vinokurova, LV | 1 |
| Grinevich, VB | 1 |
| Darvin, VV | 1 |
| Dubtsova, EA | 1 |
| Dyuzheva, TG | 1 |
| Egorov, VI | 1 |
| Efanov, MG | 1 |
| Izrailov, RE | 1 |
| Korobka, VL | 1 |
| Kotiv, BN | 1 |
| Kokhanenko, NY | 1 |
| Livzan, MA | 1 |
| Lyadov, VK | 1 |
| Nikolskaya, KA | 1 |
| Osipenko, MF | 2 |
| Pasechnikov, VD | 1 |
| Plotnikova, EY | 1 |
| Sablin, OA | 1 |
| Simanenkov, VI | 1 |
| Tsvirkun, VV | 1 |
| Tsukanov, VV | 1 |
| Shabunin, AV | 1 |
| Bordin, DS | 1 |
| Salhi, A | 1 |
| Amara, S | 1 |
| Mansuelle, P | 1 |
| Puppo, R | 1 |
| Lebrun, R | 1 |
| Gontero, B | 1 |
| Aloulou, A | 3 |
| Carrière, F | 6 |
| Pongprasobchai, S | 1 |
| Usborne, AL | 1 |
| Smith, AT | 1 |
| Engle, SK | 1 |
| Watson, DE | 1 |
| Sullivan, JM | 1 |
| Walgren, JL | 1 |
| Haupt, ME | 1 |
| Kwasny, MJ | 1 |
| Schechter, MS | 1 |
| McColley, SA | 1 |
| Kahl, S | 1 |
| Schütte, K | 1 |
| Glasbrenner, B | 1 |
| Mayerle, J | 1 |
| Simon, P | 1 |
| Henniges, F | 3 |
| Sander-Struckmeier, S | 2 |
| Lerch, MM | 2 |
| Bénarouche, A | 1 |
| Point, V | 1 |
| Cavalier, JF | 1 |
| Rouse, R | 1 |
| Zhang, L | 1 |
| Shea, K | 1 |
| Zhou, H | 1 |
| Xu, L | 1 |
| Stewart, S | 1 |
| Rosenzweig, B | 1 |
| Zhang, J | 1 |
| Goncharova, K | 3 |
| Grujic, D | 1 |
| Kirko, S | 1 |
| Szwiec, K | 4 |
| Wang, J | 1 |
| Kovalenko, T | 3 |
| Osadchenko, I | 3 |
| Fedkiv, O | 3 |
| Majda, B | 1 |
| Prykhodko, O | 4 |
| Crosby, J | 1 |
| Bellin, MD | 1 |
| Radosevich, DM | 1 |
| Chinnakotla, S | 1 |
| Dunn, TB | 1 |
| Pruett, TL | 1 |
| Freeman, ML | 1 |
| Beilman, GJ | 1 |
| Schwarzenberg, SJ | 1 |
| Cherniavskiĭ, VV | 1 |
| Lozinska, L | 1 |
| Sureda, EA | 1 |
| Podgurniak, P | 1 |
| Weström, B | 4 |
| Mascarenhas, MR | 1 |
| Mondick, J | 1 |
| Barrett, JS | 1 |
| Wilson, M | 1 |
| Stallings, VA | 2 |
| Schall, JI | 2 |
| Woestenenk, JW | 1 |
| van der Ent, CK | 1 |
| Houwen, RH | 1 |
| Lukashevich, GM | 1 |
| Schué, M | 1 |
| Puccinelli, D | 2 |
| Milano, S | 1 |
| Delchambre, C | 1 |
| Leblond, Y | 2 |
| Laugier, R | 4 |
| Lowe, ME | 1 |
| Whitcomb, DC | 1 |
| Yang, W | 1 |
| Gao, J | 1 |
| Tai, Y | 1 |
| Chen, M | 1 |
| Huang, L | 1 |
| Wen, S | 1 |
| Huang, Z | 2 |
| Liu, R | 2 |
| Li, J | 2 |
| Tang, C | 2 |
| Conwell, DL | 1 |
| Bolton, TA | 1 |
| Cook, A | 1 |
| Steiner, JM | 2 |
| Fosgate, GT | 1 |
| Heubi, JE | 1 |
| Schaeffer, D | 1 |
| Ahrens, RC | 1 |
| Sollo, N | 1 |
| Strausbaugh, S | 1 |
| Graff, G | 1 |
| Jain, R | 1 |
| Witte, S | 1 |
| Forssmann, K | 1 |
| Brock, A | 1 |
| Aldag, I | 1 |
| Edskes, S | 1 |
| Hartmann, M | 1 |
| Herzog, T | 1 |
| Uhl, W | 1 |
| Schnekenburger, J | 1 |
| Campbell, JA | 1 |
| Sanders, DS | 1 |
| Francis, KA | 1 |
| Kurien, M | 1 |
| Lee, S | 1 |
| Taha, H | 1 |
| Ramadas, A | 1 |
| Joy, D | 1 |
| Hopper, AD | 1 |
| Gliwicz, D | 1 |
| Jankowska, I | 1 |
| Wierzbicka, A | 1 |
| Miśkiewicz-Chotnicka, A | 1 |
| Lisowska, A | 2 |
| Walkowiak, J | 2 |
| Alfaro Cruz, L | 1 |
| Parniczky, A | 1 |
| Mayhew, A | 1 |
| Hornung, LN | 1 |
| Lin, TK | 1 |
| Palermo, JJ | 1 |
| Jackson, K | 1 |
| Abu-El-Haija, M | 1 |
| Venzhina, IuIu | 1 |
| Löhr, JM | 1 |
| Hummel, FM | 1 |
| Pirilis, KT | 1 |
| Steinkamp, G | 1 |
| Körner, A | 1 |
| Zhou, C | 1 |
| Wang, R | 1 |
| Turki, S | 1 |
| Mrabet, G | 1 |
| Jabloun, Z | 1 |
| Destain, J | 1 |
| Thonart, P | 1 |
| Kallel, H | 1 |
| Watson, PJ | 2 |
| Archer, J | 1 |
| Roulois, AJ | 1 |
| Scase, TJ | 1 |
| Herrtage, ME | 1 |
| Keller, J | 4 |
| Brückel, S | 1 |
| Jahr, C | 1 |
| Layer, P | 6 |
| Wier, HA | 1 |
| Kuhn, RJ | 1 |
| Borowitz, D | 4 |
| Stevens, C | 3 |
| Brettman, LR | 2 |
| Campion, M | 2 |
| Chatfield, B | 1 |
| Cipolli, M | 1 |
| Wilschanski, M | 1 |
| Thompson, H | 1 |
| Hagedorn, J | 1 |
| Svendsen, A | 1 |
| Borch, K | 1 |
| Otzen, DE | 1 |
| Valverde Piedra, JL | 2 |
| Gruijc, D | 2 |
| Szymanczyk, S | 1 |
| Swieboda, P | 2 |
| Kruszewska, D | 3 |
| Filip, R | 2 |
| Botermans, J | 2 |
| Svendsen, J | 2 |
| Skibo, G | 2 |
| Proesmans, M | 2 |
| De Boeck, K | 2 |
| Gewert, K | 1 |
| Holowachuk, SA | 1 |
| Rippe, C | 1 |
| Gregory, PC | 2 |
| Erlanson-Albertsson, C | 1 |
| Olivecrona, G | 1 |
| Piedra, JV | 1 |
| Nousia-Arvanitakis, S | 1 |
| Piotrowski, R | 1 |
| Strzykala, K | 1 |
| Bychowiec, B | 1 |
| Songin, T | 1 |
| Galli-Tsinopoulou, A | 1 |
| Sands, D | 1 |
| Pidonia, I | 1 |
| Krawczynski, M | 1 |
| Milanowski, A | 1 |
| Herzig, KH | 1 |
| Migliori, M | 1 |
| Pezzilli, R | 1 |
| Tomassetti, P | 1 |
| Gullo, L | 2 |
| Mosler, K | 1 |
| von Kries, R | 1 |
| Vermeer, C | 1 |
| Saupe, J | 1 |
| Schmitz, T | 1 |
| Schuster, A | 1 |
| El-Hodhod, MA | 1 |
| Nassar, MF | 1 |
| Hetta, OA | 1 |
| Gomaa, SM | 1 |
| Konstan, MW | 3 |
| Stern, RC | 1 |
| Trout, JR | 1 |
| Sherman, JM | 1 |
| Eigen, H | 1 |
| Wagener, JS | 1 |
| Duggan, C | 1 |
| Wohl, ME | 1 |
| Colin, P | 1 |
| Weren, M | 1 |
| Kerem, E | 2 |
| Grandval, P | 1 |
| Renou, C | 1 |
| Creutzfeldt, W | 2 |
| Gleichmann, D | 1 |
| Otto, J | 2 |
| Stöckmann, F | 1 |
| Maisonneuve, P | 1 |
| Lankisch, PG | 3 |
| Schulthess, G | 1 |
| Kolyvanos Naumann, U | 1 |
| Käser, L | 1 |
| Vetter, W | 1 |
| Rutz, GM | 1 |
| Williams, DA | 1 |
| Goss, CH | 2 |
| Hayes, D | 1 |
| Newman, L | 1 |
| O'Rourke, A | 1 |
| Wagener, J | 1 |
| Moss, R | 1 |
| Hendeles, L | 2 |
| Orenstein, D | 1 |
| Ahrens, R | 1 |
| Oermann, CM | 1 |
| Aitken, ML | 1 |
| Mahl, TC | 1 |
| Young, KR | 1 |
| Dunitz, J | 1 |
| Murray, FT | 2 |
| Sheptulin, AA | 1 |
| Limauro, S | 1 |
| Blake, K | 1 |
| Casey, S | 1 |
| Quittner, AL | 1 |
| Bentley, T | 1 |
| Sarles, J | 1 |
| Iakovenko, AV | 1 |
| Agafonova, NA | 1 |
| Iakovenko, EP | 1 |
| Garvey, MS | 1 |
| Zawie, DA | 1 |
| Westermarck, E | 1 |
| Sandholm, M | 1 |
| Worning, H | 1 |
| Dockter, G | 1 |
| Sitzmann, FC | 1 |
| Götze, H | 1 |
| Goff, JS | 1 |
| Jansen, W | 1 |
| Vulinec, M | 1 |
| Pap, A | 1 |
| Varró, V | 1 |
| Isaksson, G | 1 |
| Lundquist, I | 1 |
| Akesson, B | 1 |
| Ihse, I | 1 |
| Graham, DY | 3 |
| Dutta, SK | 4 |
| Rubin, J | 1 |
| Harvey, J | 1 |
| Tilley, DK | 1 |
| Hafkenscheid, JC | 1 |
| Hessels, M | 1 |
| Jansen, JB | 1 |
| Lamers, CB | 2 |
| Simpson, JW | 1 |
| Doxey, DL | 1 |
| Durie, PR | 5 |
| Lee, L | 1 |
| Hill, R | 1 |
| Forstner, GG | 4 |
| DiMagno, EP | 2 |
| Fredrikzon, B | 1 |
| Hernell, O | 1 |
| Bläckberg, L | 1 |
| Stafford, RJ | 1 |
| Grand, RJ | 2 |
| Grözinger, KH | 1 |
| Hill, RE | 1 |
| Davidson, GP | 1 |
| Mischler, EH | 1 |
| Parrell, S | 1 |
| Farrell, PM | 1 |
| Odell, GB | 1 |
| Bell, L | 1 |
| Linton, W | 1 |
| Corey, ML | 1 |
| Hoppe-Seyler, P | 1 |
| Gerok, W | 1 |
| Bozkurt, T | 1 |
| Braun, U | 1 |
| Leferink, S | 1 |
| Gilly, G | 1 |
| Lux, G | 1 |
| Gröger, G | 1 |
| Adler, G | 2 |
| Mundlos, S | 2 |
| Kühnelt, P | 2 |
| Dreyer, E | 1 |
| Meyer, JH | 4 |
| Hlinka, M | 1 |
| Jehn, D | 2 |
| Gu, YG | 3 |
| Dodge, JA | 3 |
| Macpherson, C | 1 |
| Doty, JE | 2 |
| Kropp, J | 2 |
| Knapp, FF | 2 |
| Weyenberg, A | 1 |
| McPherson, DW | 2 |
| Ambrose, KR | 2 |
| Callahan, AP | 2 |
| von Bergmann, K | 1 |
| Biersack, HJ | 2 |
| Bovo, P | 1 |
| Cataudella, G | 1 |
| Di Francesco, V | 1 |
| Vaona, B | 1 |
| Filippini, M | 1 |
| Marcori, M | 1 |
| Montesi, G | 1 |
| Rigo, L | 1 |
| Frulloni, L | 1 |
| Brunori, MP | 1 |
| Jones, NL | 1 |
| Hofley, PM | 1 |
| Zylberberg, P | 2 |
| Delchier, JC | 2 |
| Thomson, M | 1 |
| Clague, A | 1 |
| Cleghorn, GJ | 1 |
| Shepherd, RW | 1 |
| Kraisinger, M | 1 |
| Hochhaus, G | 1 |
| Stecenko, A | 1 |
| Bowser, E | 1 |
| Rauws, EA | 1 |
| Hoek, FJ | 1 |
| Tytgat, GN | 1 |
| Ramakrishna, J | 1 |
| Henry, JP | 1 |
| Steinberg, WM | 1 |
| Vantini, I | 2 |
| Fioretta, A | 1 |
| Bonfante, F | 1 |
| Brentegnani, MT | 1 |
| Benini, L | 2 |
| Castellani, G | 1 |
| Holtmann, G | 1 |
| Guarner, L | 1 |
| Rodríguez, R | 1 |
| Guarner, F | 1 |
| Malagelada, JR | 1 |
| Lambert, CR | 1 |
| Kirsch, G | 1 |
| Nakamura, T | 2 |
| Takebe, K | 1 |
| Kudoh, K | 1 |
| Ishii, M | 1 |
| Imamura, K | 2 |
| Kikuchi, H | 2 |
| Kasai, F | 1 |
| Tandoh, Y | 2 |
| Yamada, N | 2 |
| Arai, Y | 1 |
| O'Hare, MM | 1 |
| McMaster, C | 1 |
| Löser, C | 2 |
| Fölsch, UR | 2 |
| Regele, S | 1 |
| Henker, J | 1 |
| Münch, R | 2 |
| Barbier, Y | 1 |
| Stern, M | 1 |
| Lancellotti, L | 1 |
| Cabrini, G | 1 |
| Zanolla, L | 1 |
| Mastella, G | 1 |
| Delhaye, M | 1 |
| Meuris, S | 1 |
| Gohimont, AC | 1 |
| Buedts, K | 1 |
| Cremer, M | 1 |
| Wøjdemann, M | 2 |
| Olsen, O | 2 |
| Larsen, S | 2 |
| Sternby, B | 2 |
| Rehfeld, JF | 1 |
| Suzuki, A | 2 |
| Mizumoto, A | 2 |
| Sarr, MG | 2 |
| Opekun, AR | 1 |
| Sutton, FM | 1 |
| Swart, GR | 1 |
| Baartman, EA | 1 |
| Wattimena, JL | 1 |
| Rietveld, T | 1 |
| Overbeek, SE | 1 |
| van den Berg, JW | 1 |
| Montalto, G | 1 |
| D'Angelo, P | 1 |
| Lo Casto, A | 1 |
| Carroccio, A | 1 |
| Soresi, M | 1 |
| Midiri, M | 1 |
| Malizia, R | 1 |
| Scafidi, V | 1 |
| Stevens, JC | 1 |
| Maguiness, KM | 1 |
| Hollingsworth, J | 1 |
| Heilman, DK | 1 |
| Chong, SK | 1 |
| Terada, A | 1 |
| Watanabe, T | 1 |
| Kaji, A | 1 |
| Suda, T | 1 |
| Browning, T | 1 |
| Rerknimitr, R | 1 |
| DiMango, EP | 1 |
| Carrère, J | 1 |
| Guy-Crotte, O | 1 |
| Gaia, E | 1 |
| Figarella, C | 1 |
| Hershkovits, BS | 1 |
| Dagan, J | 1 |
| Freier, S | 1 |
| Nassir, F | 1 |
| Davidson, NO | 1 |
| Augarten, A | 1 |
| Shmilovich, H | 1 |
| Doolman, R | 1 |
| Aviram, M | 1 |
| Akons, H | 1 |
| Ben Tur, L | 1 |
| Blau, H | 1 |
| Rivlin, J | 1 |
| Sela, BA | 1 |
| Szeinberg, A | 1 |
| Yahav, Y | 1 |
| Tchoua, U | 1 |
| Ito, M | 1 |
| Okamoto, M | 1 |
| Tojo, H | 1 |
| Lark, RK | 1 |
| Lester, GE | 1 |
| Ontjes, DA | 1 |
| Blackwood, AD | 1 |
| Hollis, BW | 1 |
| Hensler, MM | 1 |
| Aris, RM | 1 |
| Adamama-Moraitou, KK | 1 |
| Rallis, TS | 1 |
| Prassinos, NN | 1 |
| Papasteriadis, A | 1 |
| Roubies, N | 1 |
| Bardoń, A | 1 |
| Nowakowska, A | 1 |
| Bozkowa, K | 1 |
| Richter, T | 1 |
| Müller, D | 1 |
| Senger, H | 1 |
| Beyreiss, K | 1 |
| Morrison, G | 1 |
| Morrison, JM | 1 |
| Redmond, AO | 1 |
| Byers, CA | 1 |
| McCracken, KJ | 1 |
| Guilford, SA | 1 |
| Bowden, MW | 1 |
| al-Modaris, FI | 1 |
| Power, MJ | 1 |
| McConnell, JG | 1 |
| Taylor, IC | 1 |
| Armstrong, E | 1 |
| Buchanan, KD | 1 |
| Muench, R | 1 |
| Ammann, R | 1 |
| Lechowski, R | 1 |
| Pisarski, J | 1 |
| Gosławski, J | 1 |
| Lenarcik, M | 1 |
| Vidon, N | 1 |
| Saint-Marc Girardin, MF | 1 |
| Soule, JC | 1 |
| Moulin, C | 1 |
| Huchet, B | 1 |
| Moreau, J | 2 |
| Bouisson, M | 2 |
| Balas, D | 1 |
| Ravaud, A | 1 |
| Stupnik, S | 1 |
| Buscail, L | 1 |
| Vaysse, N | 1 |
| Ribet, A | 2 |
| Murphy, MS | 1 |
| Eastham, EJ | 1 |
| Nelson, R | 1 |
| Aynsley-Green, A | 1 |
| Williams, J | 1 |
| MacDonald, A | 1 |
| Weller, PH | 1 |
| Fields, J | 1 |
| Pandov, H | 1 |
| Andersen, JR | 1 |
| Bendtsen, F | 1 |
| Ovesen, L | 1 |
| Pedersen, NT | 1 |
| Rune, SJ | 1 |
| Tage-Jensen, U | 1 |
| Ligumsky, M | 1 |
| Granot, E | 1 |
| Branski, D | 1 |
| Stankiewicz, H | 1 |
| Goldstein, R | 1 |
| Braga, M | 1 |
| Zerbi, A | 1 |
| Dal Cin, S | 1 |
| De Franchis, R | 1 |
| Malesci, A | 1 |
| Di Carlo, V | 1 |
| Kehl, O | 1 |
| Bühler, H | 1 |
| Pei, P | 1 |
| Ammann, RW | 1 |
| Abello, J | 1 |
| Pascaud, X | 1 |
| Simoes-Nunes, C | 1 |
| Cuber, JC | 1 |
| Junien, JL | 1 |
| Rozé, C | 1 |
| Saloniemi, H | 1 |
| Kalima, TV | 1 |
| Rahko, T | 1 |
| Roberts, IM | 1 |
| Morrow, JD | 1 |
| Griffin, SM | 1 |
| Alderson, D | 1 |
| Farndon, JR | 1 |
| Gregar, I | 1 |
| Kojecký, Z | 1 |
| Matlocha, Z | 1 |
| Brugge, WR | 1 |
| Goldberg, HJ | 1 |
| Burke, CA | 1 |
| Depping, BJ | 1 |
| Hubbard, VS | 2 |
| Appler, M | 1 |
| Zerega, J | 1 |
| Lerner, S | 1 |
| Gosselin, M | 1 |
| Saint-Marc-Girardin, MF | 1 |
| Pignal, F | 1 |
| Bommelaer, G | 1 |
| Gerber, B | 1 |
| Siegmund, E | 1 |
| Dummler, W | 1 |
| Gerber, S | 1 |
| Moreau, H | 1 |
| Sauniere, JF | 1 |
| Gargouri, Y | 1 |
| Pieroni, G | 1 |
| Verger, R | 1 |
| Sarles, H | 1 |
| De Clercq, R | 1 |
| Lembcke, B | 1 |
| Göke, B | 1 |
| Freise, J | 1 |
| Horstkotte, H | 1 |
| Weizman, Z | 1 |
| Kopelman, HR | 1 |
| Vesely, SM | 1 |
| Abrams, CK | 1 |
| Hamosh, M | 1 |
| Hamosh, P | 1 |
| Cavallini, G | 1 |
| Piubello, W | 1 |
| Brocco, G | 1 |
| Micciolo, R | 1 |
| Chech, G | 1 |
| Angelini, G | 1 |
| Riela, A | 1 |
| Dalle Molle, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Gallstone Characteristics for the Severity of Acute Gallstone Pancreatitis[NCT05498961] | 301 participants (Actual) | Observational | 2022-08-10 | Completed | |||
| Immediate Endoscopic Necrosectomy vs. On-demand Necroectomy in Infected Walled-off Pancreatic Necrosis[NCT05530772] | 50 participants (Anticipated) | Interventional | 2022-09-12 | Recruiting | |||
| Impact of Exocrine Pancreatic Insufficiency Associated With Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy on Gut Microbiota, Immunological Changes and Quality of Life[NCT05480241] | 84 participants (Anticipated) | Interventional | 2022-05-01 | Recruiting | |||
| Proton Pump Inhibitors (PPI) and Fat Absorption in Subjects With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)[NCT03551691] | Phase 2 | 19 participants (Actual) | Interventional | 2018-08-07 | Completed | ||
| A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis[NCT01710644] | Phase 1/Phase 2 | 35 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| The Incidence of Pancreatic Exocrine Insufficiency and the Benefits of Pancreatic Enzyme Supplementation in Critically Ill Adult Patients[NCT01753024] | 362 participants (Actual) | Observational [Patient Registry] | 2012-01-31 | Completed | |||
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Crossover Study to Evaluate the Effectiveness and Safety of PANCRECARB® MS-16 (Pancrelipase) in Reducing Steatorrhea in Children and Adults With Cystic Fibrosis[NCT00432861] | Phase 3 | 29 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism[NCT00881452] | Phase 3 | 182 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| Pancreatic Enzyme Replacement Therapy (PERT) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer[NCT02985801] | Phase 1/Phase 2 | 16 participants (Actual) | Interventional | 2016-12-31 | Terminated (stopped due to Study was terminated due to difficulty in recruiting subjects.) | ||
| Enzyme Substitution in Exocrine Pancreatic Insufficiency; Self Administration Against a Fixed Dose Regimen[NCT01430234] | Phase 4 | 10 participants (Actual) | Interventional | 2011-10-31 | Completed | ||
| A Pilot Study Evaluating Single, High-dose Pharmacokinetics/Pharmacodynamics of Vitamin D3 in CF[NCT03734744] | 6 participants (Actual) | Interventional | 2019-06-17 | Terminated (stopped due to Clinical research currently on hold) | |||
| Double-blind Randomized Study to Determine the Efficacy of Intramuscular Vitamin D3 Supplementation in Tropical Calcific Pancreatitis[NCT00956839] | Phase 4 | 40 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| Phase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CF[NCT00406536] | Phase 2 | 110 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percentage of patients in each group with serum 25 hydroxy vitamin D >30 ng/ml (NCT00956839)
Timeframe: 6 months post intervention
| Intervention | percentage of patients (Number) |
|---|---|
| IM Vitamin D3 3,00,000 Units | 85 |
| IM Vitamin D3 6,00,000 Units | 29 |
| Oral Vitamin D3 | 0 |
Serum total calcium (mg/dL) at time points 0, 1, 3 and 6 months (NCT00956839)
Timeframe: 0, 1, 3, 6 months post intervention
| Intervention | mg/dL (Mean) | |||
|---|---|---|---|---|
| baseline | 1 month | 3 months | 6 months | |
| IM Vitamin D3 3,00,000 Units | 9.20 | 9.28 | 9.40 | 9.40 |
| IM Vitamin D3 6,00,000 Units | 9.56 | 9.52 | 9.44 | 9.40 |
| Oral Vitamin D3 | 9.24 | 9.28 | 9.40 | 9.28 |
28 reviews available for 1-anilino-8-naphthalenesulfonate and Pancreatic Insufficiency
| Article | Year |
|---|---|
Acute pancreatitis.
Topics: Amylases; Anti-Bacterial Agents; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy; D | 2020 |
Acute pancreatitis.
Topics: Amylases; Anti-Bacterial Agents; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy; D | 2020 |
Acute pancreatitis.
Topics: Amylases; Anti-Bacterial Agents; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy; D | 2020 |
Acute pancreatitis.
Topics: Amylases; Anti-Bacterial Agents; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy; D | 2020 |
The Role of Sphere Size in the Context of Pancreatin Therapy for Exocrine Pancreatic Insufficiency: A Systematic Review.
Topics: Duodenum; Exocrine Pancreatic Insufficiency; Gastric Emptying; Humans; Lipase; Pancreatin | 2021 |
A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.
Topics: Age Factors; Age of Onset; Cystic Fibrosis; Dietary Fats; Digestive System Surgical Procedures; Enzy | 2017 |
Options for addressing exocrine pancreatic insufficiency in patients receiving enteral nutrition supplementation.
Topics: Dietary Fats; Energy Intake; Enteral Nutrition; Enzyme Replacement Therapy; Exocrine Pancreatic Insu | 2017 |
Maldigestion from pancreatic exocrine insufficiency.
Topics: Administration, Oral; Atherosclerosis; Breath Tests; Cardiovascular Diseases; Diet, Fat-Restricted; | 2013 |
[Cholestasis and pancreatic insufficiency: how to start treatment?].
Topics: Cholestasis; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Replacement Therapy; Ex | 2014 |
Challenges and Updates in the Management of Exocrine Pancreatic Insufficiency.
Topics: Diet, Fat-Restricted; Dietary Fats; Enzyme Replacement Therapy; Exocrine Pancreatic Insufficiency; H | 2016 |
Pancreatic exocrine insufficiency: diagnosis and treatment.
Topics: Breath Tests; Enzyme Replacement Therapy; Exocrine Pancreatic Insufficiency; Feeding Behavior; Human | 2011 |
Pancreatic enzyme supplementation.
Topics: Amylases; Cystic Fibrosis; Drug Approval; Enzyme Replacement Therapy; Exocrine Pancreatic Insufficie | 2011 |
Lipase supplementation therapy: standards, alternatives, and perspectives.
Topics: Animals; Bacteria; Cattle; Celiac Disease; Chronic Disease; Exocrine Pancreatic Insufficiency; Fats; | 2003 |
[Chronic pancreatitis. Main symptoms: chronic abdominal pain, weight loss in steatorrhea, secondary diabetes mellitus].
Topics: Abdominal Pain; Adult; Cholangiopancreatography, Endoscopic Retrograde; Chronic Disease; Diabetes Me | 2005 |
[Modern principles of the diagnostics and enzyme therapy of exocrine pancreatic insufficiency].
Topics: Breath Tests; Exocrine Pancreatic Insufficiency; Humans; Lipase; Trypsin | 2006 |
Pancreatic enzyme therapy for pancreatic exocrine insufficiency.
Topics: Exocrine Pancreatic Insufficiency; Feeding Behavior; Gastric Emptying; Humans; Lipase; Microspheres; | 2007 |
Feline pancreatic disease.
Topics: Amylases; Amyloidosis; Animals; Bilirubin; Blood Glucose; Cat Diseases; Cats; Clinical Enzyme Tests; | 1984 |
[Examination of pancreatic function in children with special reference to the PABA-test (author's transl)].
Topics: 4-Aminobenzoic Acid; Acute Disease; Aminobenzoates; Amylases; Child; Child, Preschool; Chronic Disea | 1980 |
[New facts on the diagnosis of exocrine pancreatic insufficiency in carnivora].
Topics: 4-Aminobenzoic Acid; Alkaline Phosphatase; Amylases; Animals; Atrophy; Carnivora; Chymotrypsin; Dog | 1980 |
Hereditary disease of the exocrine pancreas.
Topics: Adolescent; Adult; alpha 1-Antitrypsin Deficiency; Child; Child, Preschool; Cystic Fibrosis; Exocrin | 1982 |
Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
Topics: Amylases; Exocrine Pancreatic Insufficiency; Gastric Emptying; Humans; Intestinal Mucosa; Lipase; Pa | 1993 |
New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
Topics: Amylases; Breath Tests; Celiac Disease; Cholesterol Esters; Duodenum; Exocrine Pancreatic Insufficie | 1993 |
Colonic strictures in cystic fibrosis.
Topics: Colonic Diseases; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; Intestinal Diseases; I | 1995 |
[Treatment of exocrine pancreatic insufficiency: what gastroprotection do pancreatic enzymes provide?].
Topics: Adolescent; Adult; Antacids; Capsules; Child; Chronic Disease; Cystic Fibrosis; Enzymes, Immobilized | 1993 |
Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
Topics: Adolescent; Chemistry, Pharmaceutical; Child; Child, Preschool; Cystic Fibrosis; Exocrine Pancreatic | 1994 |
[Therapy with pancreatic enzyme preparations].
Topics: Chronic Disease; Enzyme Therapy; Exocrine Pancreatic Insufficiency; Humans; Lipase; Pancreatic Extra | 1993 |
[Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
Topics: Exocrine Pancreatic Insufficiency; Forecasting; Humans; Lipase; Pancreatic Extracts; Pancreatic Func | 1995 |
Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease.
Topics: Amylases; Chronic Disease; Digestion; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Ga | 1999 |
[Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
Topics: Alcoholism; Amylases; Celiac Disease; Endopeptidases; Exocrine Pancreatic Insufficiency; Histamine H | 1991 |
Enzyme therapy for malabsorption in exocrine pancreatic insufficiency.
Topics: Dietary Fats; Enzyme Therapy; Enzymes; Exocrine Pancreatic Insufficiency; Humans; Lipase; Malabsorpt | 1989 |
Pancreatic enzyme replacement therapy.
Topics: Adult; Capsules; Celiac Disease; Child; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; | 1989 |
32 trials available for 1-anilino-8-naphthalenesulfonate and Pancreatic Insufficiency
| Article | Year |
|---|---|
Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
Topics: Adult; Aged; Amylases; Biological Availability; Cholecystokinin; Chymotrypsin; Cross-Over Studies; D | 2020 |
The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study.
Topics: Abdominal Pain; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Amylases; APACH | 2014 |
Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Fatty Acids; Female; H | 2015 |
Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.
Topics: Adolescent; Child; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Exocrine Pancreatic Ins | 2016 |
International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
Topics: Adolescent; Adult; Amylases; Child; Cystic Fibrosis; Double-Blind Method; Enzyme Replacement Therapy | 2011 |
Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
Topics: Adolescent; Adult; Amylases; Child; Cystic Fibrosis; Drug Administration Schedule; Enzyme Replacemen | 2012 |
Exogenous pancreatic-like enzymes are recovered in the gut and improve growth of exocrine pancreatic insufficient pigs.
Topics: Amylases; Animals; Body Weight; Dose-Response Relationship, Drug; Exocrine Pancreatic Insufficiency; | 2012 |
Behavioral changes in response to feeding pancreatic-like enzymes to exocrine pancreatic insufficiency pigs.
Topics: Amylases; Animals; Aspergillus; Burkholderia cepacia; Cross-Over Studies; Exocrine Pancreatic Insuff | 2012 |
Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
Topics: Adolescent; Adult; Aged; Child; Cross-Over Studies; Cystic Fibrosis; Double-Blind Method; Exocrine P | 2004 |
Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients.
Topics: Adolescent; Adult; Amylases; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Humans; Lip | 2006 |
Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis.
Topics: Adolescent; Adult; Amylases; Analysis of Variance; Blood Glucose; Child; Cystic Fibrosis; Dose-Respo | 2006 |
Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
Topics: Amylases; Celiac Disease; Chronic Disease; Clinical Trials as Topic; Exocrine Pancreatic Insufficien | 1984 |
Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Topics: Adult; Dietary Fats; Duodenum; Evaluation Studies as Topic; Exocrine Pancreatic Insufficiency; Feces | 1983 |
The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
Topics: Adult; Evaluation Studies as Topic; Exocrine Pancreatic Insufficiency; Humans; Hydrogen-Ion Concentr | 1983 |
Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
Topics: Adolescent; Child; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; Lipase; Malabsorption | 1982 |
Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
Topics: Adolescent; Bicarbonates; Celiac Disease; Child; Cimetidine; Cystic Fibrosis; Dietary Fats; Drug The | 1980 |
Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
Topics: Amino Acid Sequence; Child; Exocrine Pancreatic Insufficiency; Humans; Intestinal Absorption; Lipase | 1993 |
Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy.
Topics: Adult; Aged; Celiac Disease; Cimetidine; Double-Blind Method; Exocrine Pancreatic Insufficiency; Fem | 1994 |
Fate of oral enzymes in pancreatic insufficiency.
Topics: Celiac Disease; Delayed-Action Preparations; Duodenum; Exocrine Pancreatic Insufficiency; Feces; Fem | 1993 |
Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
Topics: Adolescent; Adult; Child; Child, Preschool; Chymotrypsin; Cystic Fibrosis; Double-Blind Method; Exoc | 1996 |
High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial.
Topics: Adolescent; Adult; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Fats; Exocrine Pancreatic Ins | 1996 |
Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Topics: Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Exocrine Pancreatic Ins | 1996 |
Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
Topics: Adult; Celiac Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Exocrine Pancreatic Ins | 1997 |
Cephalic phase of lipolysis is impaired in pancreatic insufficiency: role of gastric lipase.
Topics: Adult; Biopsy; Chronic Disease; Endoscopy, Digestive System; Enteral Nutrition; Exocrine Pancreatic | 2000 |
Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Child; Child, Preschool; Cystic Fibrosis; Dose-Respons | 1992 |
[Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity].
Topics: Adult; Breath Tests; Double-Blind Method; Duodenum; Exocrine Pancreatic Insufficiency; Humans; Lipas | 1991 |
Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations.
Topics: Adult; Bile Acids and Salts; Celiac Disease; Chymotrypsin; Exocrine Pancreatic Insufficiency; Feces; | 1991 |
Two enteric coated microspheres in cystic fibrosis.
Topics: Adolescent; Body Weight; Capsules; Child; Child, Preschool; Cystic Fibrosis; Dietary Fats; Exocrine | 1990 |
Maximal effective dose of cerulein in the secretin-cerulein test.
Topics: Adult; Bicarbonates; Ceruletide; Chronic Disease; Chymotrypsin; Clinical Trials as Topic; Exocrine P | 1988 |
Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Topics: Adult; Cystic Fibrosis; Delayed-Action Preparations; Drug Evaluation; Duodenum; Exocrine Pancreatic | 1988 |
[Comparison of fungal lipase and pancreatic lipase in exocrine pancreatic insufficiency in man. Study of their in vitro properties and intraduodenal bioavailability].
Topics: Bile Acids and Salts; Biological Availability; Colipases; Duodenum; Eating; Exocrine Pancreatic Insu | 1988 |
Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
Topics: Celiac Disease; Chronic Disease; Cimetidine; Clinical Trials as Topic; Drug Therapy, Combination; Ex | 1986 |
126 other studies available for 1-anilino-8-naphthalenesulfonate and Pancreatic Insufficiency
| Article | Year |
|---|---|
Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study.
Topics: Adult; Cross-Sectional Studies; Cystic Fibrosis; Enzyme Replacement Therapy; Exocrine Pancreatic Ins | 2022 |
Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines-A cross-sectional observational study.
Topics: Enzyme Replacement Therapy; Exocrine Pancreatic Insufficiency; Humans; Lipase; Pancreatic Elastase; | 2022 |
An Unusual Cause of Diarrhea in Young Adulthood.
Topics: Adult; Diarrhea; Exocrine Pancreatic Insufficiency; Humans; Lipase; Pancreas, Exocrine; Young Adult | 2023 |
Validation of an omega-3 substrate challenge absorption test as an indicator of global fat lipolysis.
Topics: Animals; Exocrine Pancreatic Insufficiency; Fatty Acids, Omega-3; Humans; Intestinal Absorption; Lip | 2023 |
Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia.
Topics: Adult; Aged; Amylases; Betacoronavirus; China; Coronavirus Infections; COVID-19; Exocrine Pancreatic | 2020 |
Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS.
Topics: Commonwealth of Independent States; Drug Liberation; Exocrine Pancreatic Insufficiency; Gastrointest | 2020 |
Fecal elastase levels in children diagnosed with functional abdominal pain-not otherwise specified.
Topics: Abdominal Pain; Child; Exocrine Pancreatic Insufficiency; Feces; Humans; Lipase; Pancreatic Elastase | 2021 |
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Exocrine Pancr | 2021 |
Difference in Performance of EPI Pigs Fed Either Lipase-Predigested or Creon®-Supplemented Semielemental Diet.
Topics: Animals; Astrocytes; Body Composition; Bone and Bones; Diet; Enzyme Replacement Therapy; Exocrine Pa | 2021 |
Bile salt stimulated lipase: Inhibition by phospholipids and relief by phospholipase A
Topics: Cystic Fibrosis; Dietary Fats; Exocrine Pancreatic Insufficiency; Humans; Lipase; Magnetic Resonance | 2017 |
Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy.
Topics: Adult; Antiretroviral Therapy, Highly Active; Exocrine Pancreatic Insufficiency; Feces; Female; HIV | 2018 |
Autoimmune pancreatitis after nivolumab anti-programmed death receptor-1 treatment.
Topics: Antineoplastic Agents, Immunological; Autoimmune Diseases; Biomarkers; Diffusion Magnetic Resonance | 2018 |
Russian consensus on exo- and endocrine pancreatic insufficiency after surgical treatment.
Topics: Blood Glucose; Consensus; Exocrine Pancreatic Insufficiency; Feces; Glycated Hemoglobin; Hormone Rep | 2018 |
Characterization of all the lipolytic activities in pancreatin and comparison with porcine and human pancreatic juices.
Topics: Amino Acid Sequence; Animals; Carboxylesterase; Carboxylic Ester Hydrolases; Enzyme Assays; Enzyme S | 2020 |
Biomarkers of exocrine pancreatic injury in 2 rat acute pancreatitis models.
Topics: Acute Disease; Alkenes; Amylases; Animals; Biomarkers; Ceruletide; Disease Models, Animal; Dose-Resp | 2014 |
Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
Topics: Adolescent; Body Mass Index; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; | 2014 |
An interfacial and comparative in vitro study of gastrointestinal lipases and Yarrowia lipolytica LIP2 lipase, a candidate for enzyme replacement therapy.
Topics: Animals; Bile Acids and Salts; Dogs; Enzyme Replacement Therapy; Enzyme Stability; Exocrine Pancreat | 2014 |
Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet.
Topics: Amylases; Animals; Apoptosis; Autophagy; Diet, High-Fat; Dietary Carbohydrates; Drug Administration | 2014 |
A piglet with surgically induced exocrine pancreatic insufficiency as an animal model of newborns to study fat digestion.
Topics: Animals; Body Weight; Dietary Fats, Unsaturated; Digestion; Disease Models, Animal; Exocrine Pancrea | 2014 |
Gastrointestinal symptoms before and after total pancreatectomy with islet autotransplantation: the role of pancreatic enzyme dosing and adherence.
Topics: Adolescent; Adult; Aged; Blood Glucose; Child; Child, Preschool; Enzyme Replacement Therapy; Exocrin | 2015 |
[The clinical application of 13C-breath tests in pancreatic diseases].
Topics: Adult; Aged; Amylases; Breath Tests; Carbohydrate Metabolism; Carbon Isotopes; Enzyme Replacement Th | 2014 |
Monitoring changes in plasma levels of pancreatic and intestinal enzymes in a model of pancreatic exocrine insufficiency--induced by pancreatic duct-ligation--in young pigs.
Topics: Amylases; Animals; Exocrine Pancreatic Insufficiency; Intestines; Ligation; Lipase; Pancreas; Pancre | 2015 |
Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
Topics: Adolescent; Child; Child, Preschool; Cross-Sectional Studies; Cystic Fibrosis; Diet Records; Enzyme | 2015 |
Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
Topics: Administration, Oral; Animals; Carboxylic Ester Hydrolases; Disease Models, Animal; Dogs; Enzyme Rep | 2015 |
Next Generation of Pancreatic Enzyme Replacement Therapy: Recombinant Microbial Enzymes and Finding the Perfect Lipase.
Topics: Animals; Carboxylic Ester Hydrolases; Enzyme Replacement Therapy; Exocrine Pancreatic Insufficiency; | 2015 |
Betaine Attenuates Alcohol-Induced Pancreatic Steatosis.
Topics: Adiponectin; Amylases; Animals; Betaine; Blotting, Western; Cell Line, Tumor; Central Nervous System | 2016 |
Pancreatic Lipase Immunoreactivity in Serum of Dogs with Diabetic Ketoacidosis.
Topics: Animals; Diabetic Ketoacidosis; Dog Diseases; Dogs; Exocrine Pancreatic Insufficiency; Lipase; Pancr | 2016 |
Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.
Topics: Amylases; Animal Feed; Animals; Bile Acids and Salts; Cloning, Molecular; Colorimetry; Drug Combinat | 2016 |
Should we Investigate Gastroenterology Patients for Pancreatic Exocrine Insufficiency? A Dual Centre UK Study.
Topics: Biomarkers; Clinical Enzyme Tests; Comorbidity; England; Enzyme Replacement Therapy; Exocrine Pancre | 2016 |
Exocrine pancreatic function in children with Alagille syndrome.
Topics: Adolescent; Alagille Syndrome; Breath Tests; Child; Child, Preschool; Digestion; Exocrine Pancreatic | 2016 |
Utility of Direct Pancreatic Function Testing in Children.
Topics: Amylases; Child; Child, Preschool; Chymotrypsin; Enzyme Replacement Therapy; Exocrine Pancreatic Ins | 2017 |
[Clinical features of different variants of excretory pancreatic insufficiency].
Topics: Asthenia; Diarrhea; Exocrine Pancreatic Insufficiency; Feces; Female; Humans; Lipase; Male; Middle A | 2009 |
Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
Topics: Amylases; Digestion; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Humans; Lipase; Mic | 2009 |
Irreversible exocrine pancreatic insufficiency in alcoholic rats without chronic pancreatitis after alcohol withdrawal.
Topics: Alcoholism; Amylases; Animals; Blotting, Western; Central Nervous System Depressants; Cholecystokini | 2010 |
A highly stable Yarrowia lipolytica lipase formulation for the treatment of pancreatic exocrine insufficiency.
Topics: Animals; Bile Acids and Salts; Candida; Chemistry, Pharmaceutical; Chymotrypsin; Enzyme Replacement | 2010 |
Observational study of 14 cases of chronic pancreatitis in dogs.
Topics: Abdominal Pain; Amylases; Animals; Biomarkers; Cholesterol; Clinical Enzyme Tests; Diabetes Complica | 2010 |
A modified ¹³C-mixed triglyceride breath test detects moderate pancreatic exocrine insufficiency.
Topics: Adult; Aged; Breath Tests; Caprylates; Carbon Isotopes; Exocrine Pancreatic Insufficiency; Female; G | 2011 |
Variant of the Thermomyces lanuginosus lipase with improved kinetic stability: a candidate for enzyme replacement therapy.
Topics: Ascomycota; Bile Acids and Salts; Calorimetry, Differential Scanning; Enzyme Replacement Therapy; Ex | 2013 |
Evaluation of dietary fiber intake in Belgian children with cystic fibrosis: is there a link with gastrointestinal complaints?
Topics: Adolescent; Adult; Belgium; Child; Child, Preschool; Constipation; Cystic Fibrosis; Diet Surveys; Di | 2002 |
Exocrine pancreatic insufficiency as an end stage of pancreatitis in four dogs.
Topics: Amylases; Animals; Case-Control Studies; Chronic Disease; Disease Progression; Dog Diseases; Dogs; E | 2003 |
The enzyme levels in blood are not affected by oral administration of a pancreatic enzyme preparation (Creon 10,000) in pancreas-insufficient pigs.
Topics: Administration, Oral; Animals; Dose-Response Relationship, Drug; Exocrine Pancreatic Insufficiency; | 2004 |
Serum lipase after secretin stimulation detects mild pancreatic involvement in cystic fibrosis.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Child; Cystic Fibrosis; Exocrine Pancreatic Ins | 2004 |
Exocrine pancreatic function after alcoholic or biliary acute pancreatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Amino Acids; Bicarbonates; Ceruletide; Cholelithiasis; Chymo | 2004 |
Assessment of vitamin K deficiency in CF--how much sophistication is useful?
Topics: Adolescent; Adult; Apolipoproteins E; Biomarkers; Bone Diseases, Metabolic; Case-Control Studies; Ch | 2003 |
Pancreatic size in protein energy malnutrition: a predictor of nutritional recovery.
Topics: Adolescent; Amylases; Child; Egypt; Exocrine Pancreatic Insufficiency; Female; Hemoglobins; Humans; | 2005 |
Gastric lipase and pancreatic exocrine insufficiency.
Topics: Dietary Fats; Digestion; Exocrine Pancreatic Insufficiency; Humans; Lipase | 2005 |
Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
Topics: Adult; Amylases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Panc | 2005 |
Does the pancreas really produce much more lipase than required for fat digestion?
Topics: Animals; Dietary Fats; Digestion; Exocrine Pancreatic Insufficiency; Gastrointestinal Tract; Humans; | 2005 |
Follow-up of exocrine pancreatic function in type-1 diabetes mellitus.
Topics: Adult; Amylases; Diabetes Mellitus, Type 1; Exocrine Pancreatic Insufficiency; Female; Follow-Up Stu | 2005 |
Gastrointestinal lipolysis levels and potential use of gastric lipase in pancreatic insufficiency.
Topics: Exocrine Pancreatic Insufficiency; Humans; Lipase; Lipolysis | 2005 |
Serum lipase activities and pancreatic lipase immunoreactivity concentrations in dogs with exocrine pancreatic insufficiency.
Topics: Animals; Dog Diseases; Dogs; Exocrine Pancreatic Insufficiency; Lipase; Pancreas; Statistics, Nonpar | 2006 |
Meal patterns, dietary fat intake and pancreatic enzyme use in preadolescent children with cystic fibrosis.
Topics: Anthropometry; Child; Cystic Fibrosis; Dietary Fats; Energy Intake; Exocrine Pancreatic Insufficienc | 2006 |
In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
Topics: Amylases; Animals; Biological Availability; Chymotrypsin; Duodenum; Exocrine Pancreatic Insufficienc | 2008 |
[Practical approaches to the treatment of chronic pancreatitis].
Topics: Abdominal Pain; Analgesics, Non-Narcotic; Enzyme Inhibitors; Exocrine Pancreatic Insufficiency; Hist | 2007 |
Faecal hydrolase activity as determined by radial enzyme diffusion: a new method for detecting pancreatic dysfunction in the dog.
Topics: Agar; Amylases; Animals; Dog Diseases; Dogs; Exocrine Pancreatic Insufficiency; Feces; Gels; Hydrola | 1980 |
The effect of enzyme substitution in patients with pancreatic insufficiency.
Topics: Amylases; Dose-Response Relationship, Drug; Exocrine Pancreatic Insufficiency; Gastrectomy; Humans; | 1980 |
[Exocrine pancreatic insufficiency (author's transl)].
Topics: Amino Acid Metabolism, Inborn Errors; Amylases; Cystic Fibrosis; Enteropeptidase; Enzyme Therapy; Ex | 1980 |
Pancreatic exocrine function testing.
Topics: 4-Aminobenzoic Acid; Amylases; Carbon Radioisotopes; Exocrine Pancreatic Insufficiency; Fats; Feces; | 1981 |
[Substitution of digestive enzymes in elderly patients].
Topics: Aged; Amylases; Digestive System Diseases; Double-Blind Method; Drug Therapy, Combination; Exocrine | 1982 |
Effects of pectin and wheat bran on intraluminal pancreatic enzyme activities and on fat absorption as examined with the triolein breath test in patients with pancreatic insufficiency.
Topics: Adult; Amylases; Breath Tests; Dietary Fats; Dietary Fiber; Exocrine Pancreatic Insufficiency; Femal | 1984 |
Pancreatic enzyme replacement: the effect of antacids or cimetidine.
Topics: Adult; Aluminum Hydroxide; Antacids; Bicarbonates; Calcium Carbonate; Celiac Disease; Cimetidine; Ex | 1982 |
Ins and outs of pancreatic enzymes and adjuvant therapies.
Topics: Bicarbonates; Celiac Disease; Enzyme Therapy; Exocrine Pancreatic Insufficiency; Humans; Lipase; Pan | 1984 |
Serum trypsin, alpha-amylase and lipase during bombesin stimulation in normal subjects and patients with pancreatic insufficiency.
Topics: Adolescent; Adult; alpha-Amylases; Bombesin; Exocrine Pancreatic Insufficiency; Female; Humans; Infu | 1984 |
Quantitative assessment of fat absorption and its diagnostic value in exocrine pancreatic insufficiency.
Topics: Animals; Dietary Fats; Dog Diseases; Dogs; Exocrine Pancreatic Insufficiency; Intestinal Absorption; | 1983 |
Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency.
Topics: Adolescent; Adult; Celiac Disease; Child; Child, Preschool; Colipases; Cystic Fibrosis; Exocrine Pan | 1984 |
Controversies in the treatment of exocrine pancreatic insufficiency.
Topics: Adult; Antacids; Celiac Disease; Child, Preschool; Cimetidine; Exocrine Pancreatic Insufficiency; Ga | 1982 |
Lingual lipase. Its role in lipid digestion in infants with low birthweight and/or pancreatic insufficiency.
Topics: Bile Acids and Salts; Cystic Fibrosis; Dietary Fats; Exocrine Pancreatic Insufficiency; Humans; Infa | 1982 |
[Substitution of pancreatic enzymes].
Topics: Dosage Forms; Exocrine Pancreatic Insufficiency; Humans; Lipase; Pancreas; Tablets, Enteric-Coated | 1982 |
Steatorrhea and pancreatic insufficiency in Shwachman syndrome.
Topics: Adolescent; Aging; Agranulocytosis; Celiac Disease; Child; Child, Preschool; Cystic Fibrosis; Dietar | 1982 |
Origin and development of exocrine pancreatic insufficiency in experimental renal failure.
Topics: Amylases; Animals; DNA; Exocrine Pancreatic Insufficiency; Female; Kidney Failure, Chronic; Lipase; | 1994 |
Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis.
Topics: Adult; Aged; Amylases; Bicarbonates; Chronic Disease; Exocrine Pancreatic Insufficiency; Female; Hum | 1994 |
Preduodenal mechanisms compensate completely for absent pancreatic enzymes to stimulate gallbladder after meals.
Topics: Animals; Dietary Fats; Dogs; Duodenum; Eating; Exocrine Pancreatic Insufficiency; Female; Gallbladde | 1995 |
Factors that affect the performance of lipase on fat digestion and absorption in a canine model of pancreatic insufficiency.
Topics: Animals; Dietary Fats; Dietary Fiber; Digestion; Disease Models, Animal; Dogs; Duodenum; Exocrine Pa | 1994 |
Evaluation of pancreatic lipase activity by simple urine analysis after oral administration of a new iodine-131-labeled triglyceride.
Topics: Animals; Exocrine Pancreatic Insufficiency; Humans; Iodine Radioisotopes; Iodobenzenes; Lipase; Panc | 1994 |
Intraluminal gastric pH in chronic pancreatitis.
Topics: Bicarbonates; Chronic Disease; Circadian Rhythm; Digestion; Exocrine Pancreatic Insufficiency; Femal | 1995 |
Effect of replenished lipase on postcibal absorption of fat in a canine model of pancreatic insufficiency.
Topics: Animals; Dietary Fats; Disease Models, Animal; Dogs; Exocrine Pancreatic Insufficiency; Intestinal A | 1994 |
Pathophysiology of the pancreatic defect in Johanson-Blizzard syndrome: a disorder of acinar development.
Topics: Case-Control Studies; Colipases; Consanguinity; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; | 1994 |
[Sense and nonsense in the treatment of exocrine pancreatic insufficiency].
Topics: Cholecystokinin; Enzyme Therapy; Exocrine Pancreatic Insufficiency; Humans; Lipase; Pain Management; | 1994 |
Gene therapy for exocrine pancreatic insufficiency.
Topics: Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Gallbladder; Genetic Therapy; Humans; Lipase; Pa | 1994 |
Pancreatic function tests in the rat model of chronic pancreatic insufficiency.
Topics: Absorption; Animals; Chronic Disease; Chymotrypsin; Chymotrypsinogen; Dietary Fats; Disease Models, | 1993 |
[In vitro study of a new pancreatic enzyme with high lipase content in enteric coated microtablets].
Topics: Biological Availability; Buffers; Chymotrypsin; Drug Evaluation; Duodenum; Exocrine Pancreatic Insuf | 1993 |
Site-specific/stable radioiodination of 1,2-Pal-3-IPPA: an agent for the potential clinical evaluation of pancreatic insufficiency by urine analysis.
Topics: Animals; Exocrine Pancreatic Insufficiency; Female; Iodine Radioisotopes; Iodobenzenes; Isotope Labe | 1993 |
No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.
Topics: Adult; Amylases; Cholecystokinin; Chronic Disease; Exocrine Pancreatic Insufficiency; Feedback; Food | 1995 |
Stated versus actual lipase activity in pancreatic enzyme supplements: implications for clinical use.
Topics: Dose-Response Relationship, Drug; Drug Industry; Exocrine Pancreatic Insufficiency; Food, Fortified; | 1995 |
Deficient gastric lipase secretion in pancreatic insufficiency.
Topics: Adult; Case-Control Studies; Cholecystokinin; Exocrine Pancreatic Insufficiency; Female; Gastric Muc | 1997 |
Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea?
Topics: Animals; Bacterial Proteins; Celiac Disease; Dietary Fats; Disease Models, Animal; Dogs; Exocrine Pa | 1997 |
Evaluation studies of the 13C-mixed triglyceride breath test in healthy controls and adult cystic fibrosis patients with exocrine pancreatic insufficiency.
Topics: Adult; Breath Tests; Calorimetry, Indirect; Carbon Dioxide; Carbon Isotopes; Case-Control Studies; C | 1997 |
Serum and fecal pancreatic enzymes in beta-thalassemia major.
Topics: Adolescent; Adult; Amylases; beta-Thalassemia; Chymotrypsin; Exocrine Pancreatic Insufficiency; Fats | 1997 |
Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
Topics: Adolescent; Child; Child, Preschool; Colon; Colonic Diseases; Cystic Fibrosis; Exocrine Pancreatic I | 1998 |
Effects of high-lipase pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in patients with pancreatic insufficiency resulting from chronic pancreatitis.
Topics: Adult; Aged; Bile Acids and Salts; Chronic Disease; Exocrine Pancreatic Insufficiency; Fatty Acids; | 1998 |
Exocrine pancreatic insufficiency in a cat.
Topics: Animals; Blood Chemical Analysis; Cat Diseases; Cats; Exocrine Pancreatic Insufficiency; Female; Fol | 1998 |
Effect of bacterial or porcine lipase with low- or high-fat diets on nutrient absorption in pancreatic-insufficient dogs.
Topics: Animals; Bacteria; Bacterial Proteins; Celiac Disease; Chymotrypsin; Dietary Carbohydrates; Dietary | 1999 |
Immunoreactive pancreatic Reg protein in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Topics: Adolescent; Adult; Calcium-Binding Proteins; Child; Child, Preschool; Chromatography, Gel; Chymotryp | 1999 |
Increased spontaneous chromosomal breakage in Shwachman syndrome.
Topics: Amylases; Bone Diseases, Developmental; Celiac Disease; Chromosome Breakage; Diarrhea; Exocrine Panc | 1999 |
Intestinal Apo B48 secretion: a novel surrogate marker of pancreatic exocrine function.
Topics: Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Biomarkers; Celiac Disease; Chronic Di | 1999 |
Serum lipase levels as a diagnostic marker in cystic fibrosis patients with normal or borderline sweat tests.
Topics: Adult; Child; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocr | 2000 |
Increased intestinal phospholipase A(2) activity catalyzed by phospholipase B/lipase in WBN/Kob rats with pancreatic insufficiency.
Topics: Age Factors; Amylases; Animals; Body Weight; Catalysis; Diet, Fat-Restricted; Dietary Fats; Digestiv | 2000 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Bone Density; Case-Control Studies; Cysti | 2001 |
Serum vitamin A concentration in dogs with experimentally induced exocrine pancreatic insufficiency.
Topics: Amylases; Animals; Dietary Supplements; Dogs; Enzymes; Exocrine Pancreatic Insufficiency; Female; Li | 2002 |
[Determination of the ribonuclease activity of the duodenal contents of children as a test in the differential diagnosis of cystic fibrosis and pancreatic exocrine insufficiency].
Topics: Amylases; Child; Child, Preschool; Cystic Fibrosis; Diagnosis, Differential; Duodenum; Exocrine Panc | 1979 |
[Determination of exocrine pancreatic function in childhood with the pancreozymin-secretin test].
Topics: Amylases; Child; Child, Preschool; Cholecystokinin; Cystic Fibrosis; Diagnosis, Differential; Exocri | 1992 |
Exocrine pancreatic insufficiency in presumed healthy elderly subjects.
Topics: 4-Aminobenzoic Acid; Adolescent; Adult; Aged; Aged, 80 and over; Exocrine Pancreatic Insufficiency; | 1992 |
Fecal immunoreactive lipase: a new tubeless pancreatic function test.
Topics: Adult; Celiac Disease; Chronic Disease; Clinical Enzyme Tests; Enzyme-Linked Immunosorbent Assay; Ev | 1992 |
Exocrine pancreatic insufficiency-like syndrome in giraffe.
Topics: Amylases; Animals; Artiodactyla; Diarrhea; Exocrine Pancreatic Insufficiency; Feces; Lipase; Pancrea | 1991 |
Gastric lipase in alcoholic pancreatitis. Comparison of secretive profiles following pentagastrin stimulation in normal adults and patients with pancreatic insufficiency.
Topics: Adult; Alcoholism; Duodenal Ulcer; Exocrine Pancreatic Insufficiency; Gastric Acidity Determination; | 1990 |
Non-invasive assessment of intraluminal lipolysis using a 13CO2 breath test.
Topics: Breath Tests; Caprylates; Carbon Dioxide; Carbon Isotopes; Child; Child, Preschool; Cystic Fibrosis; | 1990 |
Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization.
Topics: Adult; Aged; Bile Acids and Salts; Chronic Disease; Duodenum; Ethanol; Exocrine Pancreatic Insuffici | 1990 |
Isolated lipase and colipase deficiency in two brothers.
Topics: Adolescent; Carotenoids; Celiac Disease; Child; Colipases; Exocrine Pancreatic Insufficiency; Humans | 1990 |
Postoperative management of patients with total exocrine pancreatic insufficiency.
Topics: Adult; Aged; Body Weight; Celiac Disease; Dietary Fats; Duodenum; Exocrine Pancreatic Insufficiency; | 1990 |
[Significance of immunoreactive lipase in the diagnosis of pancreatic diseases].
Topics: Acute Disease; Adult; Aged; Amylases; Chronic Disease; Exocrine Pancreatic Insufficiency; Female; Hu | 1985 |
Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation.
Topics: Administration, Oral; Amylases; Animals; Cholecystokinin; Chymotrypsin; Disease Models, Animal; Exoc | 1989 |
Pancreatic enzyme supplementation in normal and exocrine pancreatic insufficient pigs.
Topics: Amylases; Animals; Exocrine Pancreatic Insufficiency; Female; Lipase; Male; Pancreas; Peptide Hydrol | 1989 |
Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
Topics: Animals; Celiac Disease; Chronic Disease; Dogs; Exocrine Pancreatic Insufficiency; Fungal Proteins; | 1989 |
Adsorption of alpha-amylase (EC 3.2.1.1) and lipase (EC 3.1.1.3) before and after substitution therapy in exocrine pancreatic insufficiency.
Topics: Adult; alpha-Amylases; Exocrine Pancreatic Insufficiency; Humans; Intestinal Absorption; Lipase; Mal | 1988 |
Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency.
Topics: Adult; Aged; Delayed-Action Preparations; Exocrine Pancreatic Insufficiency; Gastric Juice; Humans; | 1988 |
Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
Topics: Celiac Disease; Dietary Fats; Duodenum; Exocrine Pancreatic Insufficiency; Feces; Humans; Intestinal | 1988 |
[Treatment of exocrine pancreatic insufficiency: where can progress come from?].
Topics: Animals; Exocrine Pancreatic Insufficiency; Humans; Hydrogen-Ion Concentration; Lipase; Pancreatic E | 1988 |
[The pH dependence of lipase and trypsin activity].
Topics: Duodenum; Exocrine Pancreatic Insufficiency; Gastric Acidity Determination; Humans; Lipase; Trypsin | 1988 |
Human gastric lipase: variations induced by gastrointestinal hormones and by pathology.
Topics: Adolescent; Adult; Aged; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Gastric Mucosa; | 1988 |
[Pancreatic enzyme preparations].
Topics: Dosage Forms; Dose-Response Relationship, Drug; Exocrine Pancreatic Insufficiency; Humans; Lipase | 1988 |
[Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation].
Topics: Adult; Exocrine Pancreatic Insufficiency; Female; Gastric Acidity Determination; Humans; Lipase; Mal | 1986 |
[Pancreatic enzyme preparations].
Topics: Bile Acids and Salts; Drug Combinations; Enzyme Therapy; Exocrine Pancreatic Insufficiency; Humans; | 1987 |
Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption.
Topics: Adolescent; Adult; Bile Acids and Salts; Celiac Disease; Colipases; Cystic Fibrosis; Exocrine Pancre | 1986 |
Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency.
Topics: Alcoholism; Dietary Fats; Exocrine Pancreatic Insufficiency; Gastric Juice; Humans; Intestinal Absor | 1987 |
Salivary isoamylase in duodenal aspirates.
Topics: Adolescent; Adult; Aged; Bicarbonates; Cholecystokinin; Duodenum; Exocrine Pancreatic Insufficiency; | 1986 |
Serum PABA and fluorescein in the course of Bz-Ty-PABA and pancreolauryl test as an index of exocrine pancreatic insufficiency.
Topics: 4-Aminobenzoic Acid; Adult; Aminobenzoates; Ceruletide; Chymotrypsin; Exocrine Pancreatic Insufficie | 1985 |